Generalized cutaneous drug eruption due to strontium ranelate

Journal of the European Academy of Dermatology and Venereology

Volumn 23, Issue 3, 2009, Pages 321-322

  Boada, A ^a   Carrascosa, J M ^a   Leal, L ^a   Ferrandiz C ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

COLECALCIFEROL; CORTICOSTEROID; DIPHENHYDRAMINE; STRONTIUM RANELATE;

ADULT; ALOPECIA; CASE REPORT; CELL INFILTRATION; CLINICAL FEATURE; DISEASE DURATION; DRUG ERUPTION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EOSINOPHIL; FEMALE; GRANULOCYTE; HUMAN; HUMAN TISSUE; HYPOPIGMENTATION; LABORATORY TEST; LETTER; OSTEOPOROSIS; OUTPATIENT; PAPILLEDEMA; PAPULE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RASH; SCALP; SKIN BIOPSY; SKIN PRURITUS;

BONE DENSITY CONSERVATION AGENTS; DRUG ERUPTIONS; FEMALE; HUMANS; MIDDLE AGED; ORGANOMETALLIC COMPOUNDS; OSTEOPOROSIS, POSTMENOPAUSAL; THIOPHENES;

EID: 60049090599     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2008.02856.x     Document Type: Letter

References (5)

1. Meunier PJ, Roux C, Seeman E et al. The effects of strontium ranelate on the risk of vertebral fracture in women with osteoporosis. N Eng J Med 2004 350 : 459 468.
2. EMEA Press release, EMEA/D/417458/2007, 16 November 2007.
3. Marie PJ. Strontium ranelate: a novel mode of action optimizing bone formation and resorption. Osteoporosis Int 2005 16 : S7 S10.
4. Brönniman M, Yawalkar N. Histopathology of drug-induced exhantems: is there a role in diagnosis of drug allergy? Curr Opin Allergy Clin Immunol 2005 5 : 317 321.
5. Barbaud A, Reichert-Penetrat S, Tréchot P. The use of skin testing in the investigation of cutaneous adverse drug reactions. Br J Dermatol 1998 139 : 49 58.